Provectus Biopharmaceuticals (PVCT) Stock Chart & Stock Price History $0.09 +0.00 (+0.46%) As of 08/14/2025 01:35 PM Eastern Add Compare Share Share Chart Stock AnalysisChartHeadlinesSEC FilingsShort InterestBuy This Stock Provectus Biopharmaceuticals Stock Price Performance The Provectus Biopharmaceuticals (PVCT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 0.81%, with a year-to-date return of -27.23%. In the past month, the stock has increased 19.89%, reflecting recent market activity. As of the latest close, Provectus Biopharmaceuticals traded at $0.09 with a market cap of $36.73 million and volume of 27,416 shares. Five years ago, the stock traded at $0.09, representing a 7.51% decrease over that period. At the time, it had a market cap of $37.51 million and a volume of 298,577 shares. Receive PVCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+8.44%1 Month Performance+19.89%3 Month Performance+5.30%Year-To-Date Performance-27.23%1 Year Performance+0.81%5 Year Performance-7.51% PVCT Stock Chart for Friday, August, 15, 2025 PVCT Chart by TradingView Provectus Biopharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/14/2025$0.09$0.09+0.46%$0.09$0.0927,416 shs$36.73 million08/13/2025$0.09$0.09+0.12%$0.09$0.08106,403 shs$36.56 million08/12/2025$0.09$0.09-2.14%$0.09$0.0854,551 shs$36.52 million08/11/2025$0.08$0.09+10.17%$0.09$0.0836,538 shs$37.32 million08/08/2025$0.08$0.08+1.00%$0.08$0.0828,493 shs$33.88 million08/07/2025$0.08$0.08-5.34%$0.08$0.08276,715 shs$33.54 million08/06/2025$0.09$0.08-8.27%$0.09$0.08194,677 shs$35.43 million08/05/2025$0.09$0.09+0.55%$0.09$0.08313,760 shs$38.62 million08/04/2025$0.09$0.09-0.54%$0.09$0.08171,327 shs$38.41 million08/01/2025$0.09$0.09+5.03%$0.09$0.0854,200 shs$38.62 million Get the Latest News and Ratings for PVCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/31/2025$0.09$0.09-5.41%$0.09$0.0831,040 shs$36.77 million07/30/2025$0.10$0.09-2.63%$0.10$0.08136,005 shs$38.88 million07/29/2025$0.08$0.10+20.10%$0.11$0.08558,081 shs$39.93 million07/28/2025$0.08$0.08+5.47%$0.08$0.07199,906 shs$33.24 million07/25/2025$0.07$0.08+3.45%$0.08$0.07347,415 shs$31.52 million07/24/2025$0.07$0.07-0.55%$0.07$0.07186,102 shs$30.47 million07/23/2025$0.07$0.07+0.69%$0.07$0.07614,164 shs$30.64 million07/22/2025$0.07$0.07-0.69%$0.07$0.0714,000 shs$30.43 million07/21/2025$0.07$0.07$0.07$0.07175,785 shs$30.64 million07/18/2025$0.07$0.07-0.27%$0.07$0.07389,264 shs$30.64 million07/17/2025$0.07$0.07+2.81%$0.07$0.0743,131 shs$30.72 million07/16/2025$0.07$0.07-2.47%$0.07$0.0722,602 shs$29.88 million07/15/2025$0.07$0.07-0.41%$0.07$0.07131,010 shs$30.64 million07/14/2025$0.08$0.07-4.31%$0.08$0.07163,772 shs$30.76 million Related Companies MCRB Stock Price Chart BHST Stock Price Chart BDTX Stock Price Chart NVCT Stock Price Chart CGEN Stock Price Chart IMRX Stock Price Chart GNLX Stock Price Chart LIMN Stock Price Chart JUSHF Stock Price Chart SPRO Stock Price Chart Receive PVCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:PVCT) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Provectus Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Provectus Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access